PROGRAM MENU
Educational Program

THSNA programming is focused on presenting the most current issues in Hemostasis and Thrombosis. THSNA 2020 will include daily plenary sessions (without other concurrent sessions); four educational tracks, a Pre-Summit Workshop Day, daily ePoster sessions, oral abstract presentations of original research and an exhibit hall with commercial booths.


  Wed - Apr 22      Thu - Apr 23      Fri - Apr 24      Sat - Apr 25   

THURSDAY, APRIL 23

8:15 - 10:00 AM
PLENARY SESSION
WELCOME/PLENARY SESSION 1
Chair/Organizer: Cathy Hayward, Anne Rose, and Robert Sidonio
Sheraton Ballroom


8:00

OPENING REMARKS
Peter Kouides. THSNA President


8:15
1

ANTICOAGULANT STEWARDSHIP IN THE ERA OF NOVEL THERAPEUTICS
Allison Burnett. University of New Mexico United States


8:45
2

BUILDING FROM BASIC BIOLOGY TO IMPROVED DIAGNOSIS AND CARE
David Lillicrap1. 1Queen's University ON, Canada


9:15
3

ADAPTING TO NEW THERAPEUTIC OPTIONS: IMPLICATIONS FOR CLINICAL SERVICES AND COAGULATION LABORATORIES
Rajiv Pruthi. Mayo Clinic

9:45 - 10:30 AM
POSTER SESSION
POSTERS/EXHIBITS
Exhibit Hall - Riverwalk AB

10:30 - 12:00 PM
HEMOSTASIS / BASIC SCIENCE
HEPARIN-INDUCED THROMBOCYTOPENIA
Chair/Organizer: Gow Arepally , Rebecca Kruse-Jarres
Sheraton Ballroom 1


10:30
4

NEW APPROACHES TO THE LABORATORY DIAGNOSIS OF HIT
Anand Padmanabhan. Versiti Wisconsin/Medical College of Wisconsin


11:00
5

ROLE OF THE ENDOTHELIUM IN HIT PATHOGENESIS
Lubica Rauova. The Children's Hospital of Philadelphia/University of Pennsylvania


11:30
6

SPONTANEOUS HIT: PATHOGENESIS AND CLINICAL FEATURES
Ted Warkentin. McMaster University

10:30 - 12:00 PM
HEMOSTASIS
NOT YOUR EVERYDAY BLEEDING
Chair/Organizer: Stephanie Cloutier, Stacy Croteau
Sheraton Ballroom 5


10:30
7

BLEEDING OF UNKNOWN CAUSE
Julie Jaffray.


11:00
8

NON HEMOSTATIC ROLE OF VON WILLEBRAND FACTOR
Paula James. Queen's University


11:30
9

BEYOND THE BLOOD VESSEL, CONNECTIVE TISSUE DISORDERS
Pamela Trapane.

10:30 - 12:00 PM
LABORATORY
UPDATES ON THE NEW GUIDELINES FOR THROMBOPHILIA TESTING
Chair/Organizer: Kristi Smock, Betsy Van Cott
Chicago Ballroom 10


10:30
10

GUIDELINES ON TESTING FOR ACTIVATED PROTEIN C RESISTANCE
Dot Adcock. Laboratory Corporation of America


11:00
11

GUIDELINES ON TESTING FOR PROTEIN C AND PROTEIN S
Richard Marlar. University of New Mexico


11:30
12

GUIDELINES ON TESTING FOR ANTITHROMBIN DEFICIENCY
Betsy Van Cott. Massachusetts General Hospital

12:15 - 1:45 PM
SATELLITE SYMPOSIUM
BAYER CORPORATE LUNCH SYMPOSIA
Chicago Ballroom 7


TAKEDA CORPORATE LUNCH SYMPOSIA
Chicago Ballroom 6

2:00 - 3:30 PM
SHORT TALKS
SHORT TALKS 1
Chicago Ballroom 6


SHORT TALKS 2
Chicago Ballroom 7


SHORT TALKS 3
Chicago Ballroom 9


SHORT TALKS 4
Chicago Ballroom 10

3:30 - 4:15 PM
POSTER SESSION
POSTERS/EXHIBITS
Exhibit Hall - Riverwalk AB

4:15 - 5:45 PM
HEMOSTASIS / LABORATORY
EVALUATING FOR VON WILLEBRAND DISEASE
Chair/Organizer: Bethany Samuelson Bannow, William Nichols
Sheraton Ballroom 5


4:15
16

DIAGNOSTIC TESTING FOR VON WILLEBRAND DISEASE: TRENDS AND INSIGHTS FROM EXTERNAL QUALITY ASSESSMENTS OF NORTH AMERICAN LABORATORY PRACTICES
Jameel Abdulrehman. University Health Network


4:45
17

ASSESSMENT OF CHILDREN FOR VON WILLEBRAND DISEASE: NEW EVIDENCE ON HOW MANY TIMES WE NEED TO TEST
Bhavya Doshi. Children's Hospital of Philadelphia


5:15
18

GENETIC TESTING FOR VON WILLEBRAND DISEASE. UPDATE ON WHEN IT IS USEFUL
Veronica Flood. Medical College of Wisconsin

4:15 - 5:45 PM
BASIC SCIENCE
NEW INSIGHTS ON COAGULATION
Chair/Organizer: Kenneth Mann, Muriel Maurer
Chicago Ballroom 10


4:15
19

NEW INSIGHTS ON FACTOR XIII AND THROMBOSIS
Muriel Maurer. University of Louisville


4:45
20

ANTI-INFLAMMATORY EFFECTS OF FVIIA
LVM Rao. The University of Texas Health Science Center at Tyler


5:15
21

INITIATION OF BLOOD COAGULATION
James Morrisey. University of Michigan Medical School

4:15 - 5:45 PM
THROMBOSIS
THE CHANGING LANDSCAPE OF CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM
Chair/Organizer: James Douketis , Crystal Watson
Sheraton Ballroom 1


4:15
13

PRIMARY VTE PROPHYLAXIS IN CANCER PATIENTS
Marc Carrier. Ottawa Hospital Research Institute


4:45
14

TREATMENT OF CANCER-ASSOCIATED VTE, INCLUDING SPECIAL AND DIFFICULT PATIENT POPULATIONS.
Michael Streiff. Johns Hopkins University School of Medicine


5:15
15

CLINICAL CONTROVERSIES IN TREATING THROMBOSIS
Sam Schulman. McMaster University

5:45 - 6:30 PM
POSTER SESSION
OPENING RECEPTION/POSTERS/EXHIBITS
Exhibit Hall - Riverwalk AB

6:30 - 8:30 PM
SATELLITE SYMPOSIUM
ALNYLAM CORPORATE DINNER SYMPOSIA
Chicago Ballroom 7


PFIZER CORPORATE DINNER SYMPOSIA
Chicago Ballroom 6